drugset / Trial / NCT00992862
A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to compare the relative bioavailability of Moexipril HCl 15mg tablets (by Paddock Laboratories, Inc.) with that of Univasc® 15mg tablets (by Schwarz Pharma) following a single oral dose (1 x 15mg tablet) in healthy, adult subjects under fasting conditions.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moexipril | Small molecule | 15 mg | Oral |
Indications
No indication recorded.